HCM HUTCHMED DRC

USD 15.74 +0.54 ( +3.55%)
Icon

HUTCHMED DRC (HCM) Financial Statements

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

USD 15.74

+0.54 (+3.55%)

USD 2.63B

0.08M

USD -1.00

N/A

Icon

HCM

HUTCHMED DRC (USD)
COMMON STOCK | NSD
USD 15.74
+0.54 ( +3.55%)

HUTCHMED DRC (HCM) Annual Income Statement (USD)

HCM Quarterly Financials (USD)

Frequently Asked Questions About HUTCHMED DRC (HCM) Stock

HUTCHMED DRC's (HCM) last reported annual revenue was USD 630.20 Million.

HUTCHMED DRC's (HCM) annual revenue growth rate based on the revenue reported in the past 5 years is : 25.20%

HUTCHMED DRC's(HCM) is profitable as of its last reported annual financials.

The net profit margin for HUTCHMED DRC's(HCM) from its laster reported year is 5.99%

The return on equity (ROE) for HUTCHMED DRC's(HCM) from its last reported annual financials is : 5.04%

The return on assets (ROA) for HUTCHMED DRC's(HCM) from its last reported annual financials is : -2.14%

The return on invested capital (ROIC) for HUTCHMED DRC's(HCM) from its last reported annual financials is : -5.78%

The Debt to Equity ratio for HUTCHMED DRC's(HCM) from its last reported annual financials is : 7.82%

The dividend yield for HUTCHMED DRC's(HCM) from its laster reported year is 0.00%

HUTCHMED DRC's(HCM) has negative cash flow as of its last reported annual financials.

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...